Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Chung HC, Satoh T, Oh DY, Park SH, Kadowaki S, Wacheck V, Yamamura A, Uenaka K, Wang XA, Wijayawardana SR, Doi T. Abstract C121: A non-randomized, open-label, single-arm, phase 2 study of LY2875358 in Asian patients with MET diagnostic positive, advanced gastric cancer. Mol Cancer Ther 2015. [DOI: 10.1158/1535-7163.targ-15-c121] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

For:	Chung HC, Satoh T, Oh DY, Park SH, Kadowaki S, Wacheck V, Yamamura A, Uenaka K, Wang XA, Wijayawardana SR, Doi T. Abstract C121: A non-randomized, open-label, single-arm, phase 2 study of LY2875358 in Asian patients with MET diagnostic positive, advanced gastric cancer. Mol Cancer Ther 2015. [DOI: 10.1158/1535-7163.targ-15-c121] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Number	Cited by Other Article(s)
1	Pollmann SE, Calvert VS, Rao S, Boca SM, Madhavan S, Horak ID, Kjaer A, Petricoin EF, Kragh M, Poulsen TT. Acquired Resistance to a MET Antibody In Vivo Can Be Overcome by the MET Antibody Mixture Sym015. Mol Cancer Ther 2018;17:1259-1270. [DOI: 10.1158/1535-7163.mct-17-0787] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2017] [Revised: 01/08/2018] [Accepted: 03/07/2018] [Indexed: 11/16/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Pollmann SE, Calvert VS, Rao S, Boca SM, Madhavan S, Horak ID, Kjaer A, Petricoin EF, Kragh M, Poulsen TT. Acquired Resistance to a MET Antibody In Vivo Can Be Overcome by the MET Antibody Mixture Sym015. Mol Cancer Ther 2018;17:1259-1270. [DOI: 10.1158/1535-7163.mct-17-0787] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2017] [Revised: 01/08/2018] [Accepted: 03/07/2018] [Indexed: 11/16/2022]